EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanistic Insights into Dihydromyricetin: Redox Modulation and Kinase-Mediated Control of Disease Pathogenesis

Oluwatoyin Adenike Fabiyi iD, Ayorinde Victor Ogundele iD, Sulyman Olalekan Ibrahim iD, Hassan Ibrahim iD, Héctor Hernán Silva iD

International Journal of Molecular Sciences · 21.05.2026 · 27 (10) · 4626

DOI: 10.3390/ijms27104626 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.05.2026. Verfasst von Oluwatoyin Adenike Fabiyi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Crop Protection, Faculty of Agriculture, University of Ilorin, Ilorin 240003, Nigeria. Hauptthemen laut MEDLINE: Flavonols, Antioxidants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Agency for Research and Development, ANID Chile, Universidad de La Frontera, Temuco, Chile.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dihydromyricetin (DHM), a naturally occurring flavanonol predominantly found in medicinal plants like Ampelopsis grossedentata, has emerged as a promising source of natural antioxidants with multi-target pharmacological activities relevant to drug discovery. DHM exhibits a strong redox-modulating capacity, effectively attenuating oxidative stress and inflammation central drivers of chronic disease pathogenesis. Beyond direct radical scavenging, DHM regulates multiple redox-sensitive and kinase-mediated signalling pathways, thereby influencing key cellular processes involved in disease initiation and progression. This review synthesizes current evidence on the therapeutic potential of DHM, critically evaluating its mechanistic basis and translational prospects, with emphasis on its dual redox-driven and kinase-mediated modes of action. We detail its roles in metabolic disorders such as diabetes, obesity, and liver diseases, neuroprotection, cardio protection, and cancer prevention, focusing on the modulation of critical networks such as AMPK, PI3K/Akt, MAPK, NF-κB, and Nrf2. The interplay between these pathways underpins DHM’s efficacy across disease models. Furthermore, we highlight structure–activity relationship (SAR) analyses and molecular modelling studies that elucidate how the flavanonol scaffold, hydroxylation pattern, and stereochemistry of DHM govern its biological activities and target engagement. Key pharmacokinetic limitations, advances in extraction techniques, bioavailability challenges, and emerging formulation strategies including advanced delivery systems are discussed to address translational hurdles. Despite compelling preclinical data, the clinical translation of DHM remains constrained by limited human studies and incomplete mechanistic resolution. This review underscores the need for integrated pharmacological studies and innovative delivery approaches to translate the multifaceted promise of DHM into viable clinical interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonolsAntioxidantsHumansOxidation-ReductionAnimalsSignal TransductionOxidative StressStructure-Activity Relationship

Stichwörter der Autor:innen

bioactivitydihydromyricetindiseasesflavanolmetabolism

Substanzen

dihydromyricetinFlavonolsAntioxidants

Autor:innen und Institutionen

  • Department of Crop Protection, Faculty of Agriculture, University of Ilorin, Ilorin 240003, Nigeria.
  • Departamento de Ciencias Basicas, Facultad de Medicina, Universidad de La Frontera, Temuco 4780000, Chile.
  • Department of Industrial Chemistry, Faculty of Physical Sciences, University of Ilorin, Ilorin 240003, Nigeria.
  • Department of Chemistry, Federal University of Lafia, Lafia 950101, Nigeria.

ORCID-Profile: Oluwatoyin Adenike Fabiyi, Ayorinde Victor Ogundele, Sulyman Olalekan Ibrahim, Hassan Ibrahim, Héctor Hernán Silva

Förderung

  • National Agency for Research and Development
  • ANID Chile
  • Universidad de La Frontera, Temuco, Chile

Zitieren

APA

Fabiyi, O. A., Ogundele, A. V., Ibrahim, S. O., Ibrahim, H., & Silva, H. H. (2026). Mechanistic Insights into Dihydromyricetin: Redox Modulation and Kinase-Mediated Control of Disease Pathogenesis. International Journal of Molecular Sciences, 27(10), 4626. https://doi.org/10.3390/ijms27104626

Vancouver

Fabiyi OA, Ogundele AV, Ibrahim SO, Ibrahim H, Silva HH. Mechanistic Insights into Dihydromyricetin: Redox Modulation and Kinase-Mediated Control of Disease Pathogenesis. International Journal of Molecular Sciences. 2026;27(10):4626. doi:10.3390/ijms27104626

BibTeX
@article{Fabiyi2026,
  author = {Fabiyi, Oluwatoyin Adenike and Ogundele, Ayorinde Victor and Ibrahim, Sulyman Olalekan and Ibrahim, Hassan and Silva, Héctor Hernán},
  title = {Mechanistic Insights into Dihydromyricetin: Redox Modulation and Kinase-Mediated Control of Disease Pathogenesis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4626},
  doi = {10.3390/ijms27104626}
}
Kostenlos starten →